Paul Parren is professor of Molecular Immunology at the Leiden University Medical Center (LUMC) and a managing director and head of Research and Development at LAVA Therapeutics, a start-up biotechnology company in Utrecht and Philadelphia, PA. He advises start-up biotechnology companies and pharma on therapeutic antibody development and patents. He is an Operational Partner at Gilde Healthcare in Utrecht. He is also a member of the Board of Directors of the non-profit organization The Antibody Society and a member of the Scientific Advisory Boards of the annual Antibody Engineering and Therapeutics conferences in US and EU, Keystone Symposia on Molecular and Cellular Biology, and the Viral Immunotherapeutic Consortium, a US NIH-funded international consortium to discover and deliver antibody therapeutics against multiple families of emerging infectious diseases. He is a member of the External Advisory Group for the Scientific Research Partnership for Neglected Tropical Snakebite (SRPNTS) program sponsored by the UK Department for International Development. During his talk, Prof. Parren will talk about his career path, and share his perspective on combining academic world with industry.